Table 2 The Changes in Serum Lipid Levels.
| Â | Allicor | Placebo | ||||
|---|---|---|---|---|---|---|
Time | All | Men | Women | All | Men | Women |
| Â | (n = 26) | (n = 14) | (n = 12) | (n = 25) | (n = 14) | (n = 11) |
Total cholesterol, mg/dl | ||||||
At the baseline | 269.2 ± 11.5 | 276.9 ± 16.3 | 260.2 ± 16.5 | 252.5 ± 9.1 | 259.4 ± 14.2 | 243.8 ± 10.4 |
After 12 months | 235.7 ± 8.4* | 237.0 ± 10.7* | 234.1 ± 13.6 | 242.0 ± 6.9 | 238.9 ± 10.8* | 245.8 ± 7.9 |
HDL cholesterol, mg/dl | ||||||
At the baseline | 50.9 ± 3.6 | 45.3 ± 3.4 | 57.3 ± 6.4 | 48.7 ± 2.5 | 43.8 ± 1.8 | 54.9 ± 4.6$ |
After 12 months | 51.5 ± 3.1 | 45.0 ± 2.4 | 59.0 ± 5.5$ | 50.7 ± 2.2 | 47.1 ± 2.2 | 55.2 ± 3.8 |
Triglycerides, mg/dl | ||||||
At the baseline | 162.1 ± 19.5 | 182.1 ± 30.7 | 138.8 ± 22.0 | 127.8 ± 9.7 | 133.4 ± 12.9 | 120.6 ± 15.0 |
After 12 months | 142.9 ± 16.5 | 148.6 ± 26.5 | 136.3 ± 19.2 | 106.9 ± 6.8* | 108.6 ± 8.2* | 104.8 ± 11.7 |
LDL cholesterol, mg/dl | ||||||
At the baseline | 185.9 ± 9.3 | 195.2 ± 11.6 | 175.1 ± 14.8 | 178.3 ± 9.1 | 188.9 ± 13.5 | 164.8 ± 10.9 |
After 12 months | 155.6 ± 7.8*# | 162.3 ± 9.0* | 147.8 ± 13.3 | 169.9 ± 7.2 | 170.1 ± 11.3* | 169.6 ± 8.5 |